116 related articles for article (PubMed ID: 15204630)
21. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.
Dekker JM; Girman C; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
Circulation; 2005 Aug; 112(5):666-73. PubMed ID: 16061755
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
25. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
26. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
[TBL] [Abstract][Full Text] [Related]
27. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
[TBL] [Abstract][Full Text] [Related]
28. Hostility, anger control, and anger expression as predictors of cardiovascular disease.
Haukkala A; Konttinen H; Laatikainen T; Kawachi I; Uutela A
Psychosom Med; 2010 Jul; 72(6):556-62. PubMed ID: 20410251
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome.
Chimonas T; Athyros VG; Ganotakis E; Nicolaou V; Panagiotakos DB; Mikhailidis DP; Elisaf M;
Angiology; 2010; 61(1):49-57. PubMed ID: 20034959
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of physical fitness and the metabolic syndrome to predict vascular disease risk in older Chinese (from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort [GBCS-CVD]).
O'Hartaigh B; Jiang CQ; Thomas GN; Tsvetanov KA; Bosch JA; Cheng KK; Lam TH
Am J Cardiol; 2011 Sep; 108(6):845-50. PubMed ID: 21784386
[TBL] [Abstract][Full Text] [Related]
31. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
[TBL] [Abstract][Full Text] [Related]
32. Association of increased cardiorespiratory fitness with low risk for clustering of metabolic syndrome components in asymptomatic men.
Orakzai RH; Orakzai SH; Nasir K; Roguin A; Pimentel I; Carvalho JA; Meneghello R; Blumenthal RS; Santos RD
Arch Med Res; 2006 May; 37(4):522-8. PubMed ID: 16624653
[TBL] [Abstract][Full Text] [Related]
33. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of risk factors for cardiovascular disease in Brazilian renal transplant recipients.
Souza FC; Silva MI; Motta EM; Guimarães SS; Souza E; Torres MR
Transplant Proc; 2007 Mar; 39(2):446-8. PubMed ID: 17362755
[TBL] [Abstract][Full Text] [Related]
36. Challenges associated with metabolic syndrome.
Spinler SA
Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular risk factor prevalence among men in a large industry of northern India.
Prabhakaran D; Shah P; Chaturvedi V; Ramakrishnan L; Manhapra A; Reddy KS
Natl Med J India; 2005; 18(2):59-65. PubMed ID: 15981439
[TBL] [Abstract][Full Text] [Related]
38. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
[TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
Clin Endocrinol (Oxf); 2008 Aug; 69(2):225-30. PubMed ID: 18208579
[TBL] [Abstract][Full Text] [Related]
40. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
Ninomiya T; Kiyohara Y; Tokuda Y; Doi Y; Arima H; Harada A; Ohashi Y; Ueshima H;
Circulation; 2008 Dec; 118(25):2694-701. PubMed ID: 19106392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
